Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.


 

2020 ASCO Update on NSCLC: Neoadjuvant Chemo for Locally Advanced Disease, Gefitinib vs Chemo for EGFR+ NSCLC & Adjuvant Osimertinib ‘Practice Changing’ for Early-Stage EGFR Mutated NSCLC

95 views
July 15, 2020
0 Comments
Login to view comments. Click here to Login